B. Riley raised its price target for Neuronetics to $6 from $5 and still thinks it's a good buy.

STIM · Neuronetics, Inc.

The AI's read

The change shows B. Riley sees more possible share value than before. The report gives no reason for the higher target and no new sales or profit figures, so the positive signal comes from the firm's view, not newly reported business results.